ARGX vs INCY
argenx SE vs Incyte — AI-powered side-by-side comparison
| Metric | ARGX | INCY |
|---|
| AI Score |
69
|
72
|
| Price |
$864.40
|
$121.08
|
| P/E Ratio |
31.34×
|
14.89×
|
| ROE |
17.6%
|
24.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
89.9%
|
92.6%
|
| Debt / Equity |
0.01×
|
0.01×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
47.9
|
56.2
|
| Beta |
-0.022
|
0.769
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for ARGX versus INCY.
INCY leads by 3 points.
INCY scores 72/100 (Buy) versus ARGX at 69/100 (Buy).
ARGX Committee View
67% agreement
6 analysts
The primary driver is revenue growing 71.3% yoy -- genuine top-line momentum. The main limiting factor is price-to-book of 6.9x prices in significant intangible value. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 22.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 71.3% YoY -- genuine top-line momentum — Growth
- EPS growing 95.7% YoY — Growth
Bear Case
- Price-to-book of 6.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
INCY Committee View
100% agreement
6 analysts
The primary driver is revenue growing 26.9% yoy -- genuine top-line momentum. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 29.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
- EPS growing 80.3% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical